RecruitingNot ApplicableNCT07287943

To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.

Efficacy and Safety of Medtronic 780G Automated Insulin Delivery System in Adults With Type 1 Diabetes and Gastroparesis


Sponsor

Viral N. Shah

Enrollment

34 participants

Start Date

Feb 9, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to evaluate the efficacy and safety of Medtronic 780G automated insulin delivery system in adult persons with type 1 diabetes and gastroparesis.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing whether an advanced automated insulin pump system (Medtronic 780G) can better manage blood sugar in people with type 1 diabetes who also have gastroparesis — a condition where the stomach empties food very slowly, making blood sugar control especially difficult. **You may be eligible if...** - You are 18 or older with type 1 diabetes for at least 12 months - You have been diagnosed with gastroparesis (delayed stomach emptying) - Your HbA1c is 8.0% or higher (indicating poorly controlled blood sugar) - Your insulin regimen has been stable for at least 2 months - You are willing to use the Medtronic 780G pump with its CGM sensor **You may NOT be eligible if...** - You are under 18 - You use inhaled insulin (Afrezza) - You use any glucose-lowering medications other than insulin - You are pregnant, breastfeeding, or planning to become pregnant - You have been using an automated closed-loop insulin system for 2+ weeks continuously Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMedtronic 780G AID

Participants in Medtronic AID treatment group will use it for three months


Locations(1)

Indiana University Health, Univeristy hospital

Indianapolis, Indiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07287943


Related Trials